Novosibirsk · Russian-qualified counsel Recognised by Pravo-300 · Best Lawyers · Kommersant
Corporate & Regulatory

Russian court practice on major transaction procedure under Russian corporate law for British shareholders: 2027 update

Stanislav Lastovsky · October 2026 · 9 min read

Russian courts refined major transaction procedure for foreign shareholders in 2027. What British in-house counsel managing Russian subsidiaries must review now. Make an enquiry.

Following a sequence of decisions handed down by Russian commercial courts across the first three quarters of 2027, the procedural landscape for approving major transactions in Russian subsidiaries has shifted in ways that directly affect British parent companies and their in-house teams. Russian courts have refined their interpretation of the approval framework — drawing sharper distinctions between transaction categories, tightening the evidentiary standards for ratification, and, in several instances, invalidating transactions that were executed without formally convening a general meeting or board session in the manner now expected by the courts. For British in-house counsel responsible for governance oversight of a Russian subsidiary — whether structured as a limited liability company or a joint-stock company — the 2027 court term has clarified certain previously contested points while opening fresh areas of uncertainty that warrant careful monitoring.

§ I. What changed in Russian major transaction procedure in 2027?

The major transaction regime in Russian corporate law has always distinguished between transactions that require shareholder approval and those that fall within the competence of the company's board of directors or equivalent governing body. Under legislation governing both limited liability companies and joint-stock companies in Russia, a major transaction is broadly defined by reference to the value of the assets involved relative to the company's total asset base — a threshold that, in practice, has generated recurring disputes about how asset value is assessed, what documents must accompany the approval process, and whether procedural defects in the approval process can serve as a basis for invalidating a completed transaction.

Throughout 2026 and into the first quarter of 2027, Russian courts — particularly at the appellate and cassation levels — had been processing a backlog of invalidity claims arising from transactions entered into during periods of corporate restructuring. The patterns that have now emerged from that caseload are material. Courts have applied a more precise framing of the "value of assets" calculation, consistently rejecting the practice of valuing assets by reference to their acquisition cost rather than their market value at the time of the transaction. This is not a new statutory rule; it reflects a consolidation of judicial interpretation that has been moving in this direction for some years. What is new in 2027 is the degree of consistency with which this approach has been applied across circuits, and the weight courts are now placing on independent valuation evidence when the transacting parties dispute whether the major transaction threshold was met.

The second development concerns ratification. Russian corporate legislation provides a mechanism by which a major transaction that was executed without proper approval may be subsequently ratified by the competent corporate body. Russian courts have, during the current period, imposed a stricter procedural standard on ratification: it is no longer sufficient for the relevant body to pass a resolution acknowledging the transaction after the fact without expressly addressing the absence of prior approval. Courts have declined to treat general board or shareholder resolutions — even where they do not expressly ratify the transaction — as having a curative effect where the procedural defect was substantive.

"The 2027 caseload has moved the major transaction framework from a regime where procedural gaps could often be remedied after the fact, to one where the quality of pre-transaction governance documentation is tested directly against the outcome." — Stanislav Lastovsky, Senior Lawyer, Practice Lead — Restructuring & Insolvency, Vetrov & Partners

§ II. Which British shareholders are most affected by these changes?

The impact of the 2027 court clarifications is distributed unevenly across entity structures and ownership arrangements. British parent companies whose Russian subsidiaries operate as limited liability companies will, in most cases, hold a degree of structural influence over the approval process that joint-stock company shareholders do not automatically enjoy — the internal governance documentation of a Russian LLC is typically more flexible and capable of allocating major transaction approval to specific bodies in ways that the statutory framework for joint-stock companies does not readily accommodate. However, that flexibility is precisely where the risk lies: courts are now scrutinising whether the allocation of major transaction authority in an LLC's articles of association or participants' agreement actually reflects the decision-making process that was followed in practice.

For British multinationals operating through Russian joint-stock subsidiaries, the court clarifications on asset valuation methodology are more immediately significant. Where the Russian subsidiary's asset base includes real property, equipment, or financial instruments that have changed materially in value since acquisition — which describes a large proportion of Russian subsidiaries established before 2022 — the question of whether a given transaction crossed the major transaction threshold may now depend on a contested valuation. The in-house counsel team responsible for approving or endorsing the transaction may not have had access to an independent valuation at the time; the 2027 cases demonstrate that this gap is capable of being exploited by counterparties or minority participants seeking to invalidate completed transactions.

Under Russian insolvency legislation and general civil law, a successfully challenged major transaction may be unwound, with restitution obligations falling on the parties to the transaction. For British parent companies, the practical consequence is that a transaction entered into by a Russian subsidiary — even one involving a third party — may be set aside at the initiative of a minority participant or, in insolvency, by an appointed administrator acting on behalf of creditors. For in-house counsel managing a Russian subsidiary's governance posture, the regulatory timeline for challenging major transactions leaves limited margin for retrospective correction.

If your team is reviewing the governance documentation for a Russian subsidiary in light of the 2027 court clarifications, make an enquiry: info@vetrovpartners.com |

§ III. What should British in-house counsel do now?

The immediate priority for British in-house counsel is a documentation audit of major transactions executed by Russian subsidiaries in the period from 2024 to the present. The 2027 caseload has demonstrated that courts are willing to look closely at governance documentation from this period when evaluating invalidity claims brought by participants or third parties. An audit of this kind should assess three things: whether the transaction was correctly categorised as requiring major transaction approval; whether the approval process followed the procedures set out in the subsidiary's constituent documents; and whether any independent valuation was obtained or was required.

The second practical step is a review of the subsidiary's articles of association or charter — together with any shareholders' agreement or participants' agreement governed by Russian law — to confirm that the allocation of major transaction authority is clearly expressed and consistent with how decisions have actually been made. Where internal governance documents have fallen out of step with actual practice, the risk of a successful invalidity challenge is materially higher. This is a structural issue, not merely a documentation issue, and correcting it may require a formal amendment to the subsidiary's constituent documents approved by the relevant corporate body.

British parent companies that have not yet reviewed the governance framework of their Russian subsidiaries in light of current court interpretation should treat the 2027 caseload as a prompt to do so. The Corporate Governance practice framework for Russian subsidiaries of foreign companies provides a useful starting point for structuring this review. For companies that have already conducted a governance audit, the 2027 clarifications on ratification procedure should be reviewed against the company's existing approach to post-transaction documentation.

The firm's overview of the major transaction approval framework — Major transaction procedure under Russian corporate law — addresses the baseline statutory requirements in detail. The companion piece on strategic considerations in major transaction governance considers the options available to foreign shareholders when existing approval procedures are under challenge. For matters requiring practical assessment, the Matters section illustrates the types of mandates in which the firm has advised foreign principals on Russian subsidiary governance disputes.

§ IV. Open questions: what remains to be settled?

Several points that practitioners had expected the 2027 caseload to resolve remain contested at the level of judicial interpretation. The most significant of these concerns the interaction between Russian corporate law and the terms of shareholders' agreements governed by foreign law. British parent companies routinely hold their Russian subsidiary interests through holding structures that involve shareholders' agreements subject to English law. The extent to which a Russian court will take account of the approval requirements established in such an agreement — as distinct from those set out in the subsidiary's Russian-law constituent documents — when assessing whether the major transaction approval process was adequate remains a question on which circuit courts have not reached uniform positions.

A related uncertainty concerns the position of transactions approved by a sole corporate participant. Where the British parent company is the sole participant in a Russian LLC, the major transaction approval framework operates differently from the multi-participant context, and the 2027 cases have not yet produced clear guidance on whether the stricter ratification standard applies equally in single-participant structures. Practitioners should expect further judicial commentary on this point as the caseload continues to develop through the remainder of 2027 and into 2028.

To discuss how the 2027 court clarifications affect your Russian subsidiary's governance documentation, make an enquiry: info@vetrovpartners.com |

Frequently asked questions

Q: What specifically changed in how Russian courts treat major transaction approval in 2027? A: Russian courts have applied a more consistent and demanding standard to both the initial approval process and the ratification of major transactions executed without prior approval. On asset valuation, courts have consolidated an interpretation that requires market value — not acquisition cost — to be used when assessing whether a transaction crosses the major transaction threshold. On ratification, courts have declined to treat general corporate resolutions as having a curative effect unless they expressly address the absence of prior approval. These are interpretive developments built on existing legislation — not new statutory rules — but their consistent application across circuits in 2027 gives them practical significance that earlier inconsistency had obscured.

Q: Which British-owned Russian subsidiaries face the greatest exposure from these clarifications? A: The exposure is highest for subsidiaries whose asset base has changed materially in value since acquisition — making it genuinely arguable whether a given transaction crossed the major transaction threshold — and for subsidiaries whose internal governance practice has, over time, diverged from the procedures set out in their constituent documents. Russian limited liability companies with flexible internal governance documents are not automatically lower-risk; where practice has deviated from documented authority allocation, the risk of a successful invalidity challenge is real. Joint-stock subsidiaries with complex asset portfolios and a history of transactions entered into without independent valuations should be prioritised for governance review.

Q: What should a British parent company do immediately if it suspects a historical transaction may not have complied with the major transaction approval requirements? A: The starting point is a structured review of the transaction documentation — not a retrospective attempt to produce approval documents, which courts will scrutinise critically. Counsel should assess whether the transaction was correctly categorised, whether the approval process followed the procedures required by the subsidiary's constituent documents, and whether a ratification resolution is still legally available and advisable. Where there is an active or anticipated dispute about the transaction's validity, early instruction of Russian legal counsel with corporate governance experience is advisable before any steps are taken that could affect the evidentiary position.

Practitioner note

This briefing is general information and does not constitute legal advice. For advice on a specific matter, write in confidence to info@vetrovpartners.com.

Facing a matter like this?

Our team advises foreign clients on exactly these questions across Russia and the EAEU region. Initial 30-minute consultation — complimentary.

Make an enquiry